VISTA/NFAT Reporter Lentivirus

SKU:BHV19400279
Suppliers
LipExoGen Biotech
LipExoGen Biotech
Details Products
Overview
Click light‑blue chips for details
The VISTA/NFAT Reporter Lentivirus enables study of the VISTA immune checkpoint by constitutively expressing VISTA alongside an NFAT-driven dual Gaussia luciferase and fluorescent reporter. Sequential transduction establishes stable cell lines for quantifying NFAT activation in real time, supporting checkpoint inhibitor testing and research on tumor immune evasion. Supplied as VSV-G-pseudotyped, purified third-generation lentiviral particles for difficult-to-transfect cells.
Species Human
Receptor Target VISTA
Reporter GFP, GFP-P2A-GLuc, GLuc (+4 more)
Selection Blasticidin, GFP, Hygromycin, Puromycin
Titer 3×10⁸ VP/mL
Assay Type Immune Receptor Reporter Assay
Options selector
Catalog no. Reporter Selection Amount (TU)
TRV-0031-6S GLuc-P2A-GFP
Available Options

Select the lentiviral variant that best fits your experiment. Contact us for custom configurations.

  • Available configurations:
    • VISTA-BSD/NFAT-GLuc-GFP
  • Available amounts: 1x10^6 TU, 2x10^6 TU, 5x10^6 TU
  • Reporter options: GFP, GFP-P2A-GLuc, GLuc, GLuc-P2A-GFP, GLuc-P2A-RFP, RFP, RFP-P2A-GLuc
  • Selection marker options: Blasticidin, GFP (constitutively expressed), Hygromycin, Puromycin, RFP (constitutively expressed), Zeocin
  • Lead time: typically ships in ~7 business days
  • Storage: store at -80°C
  • Shipping: Ships on dry ice
  • Custom orders: LipExoGen offers custom reporter/selection combinations at no extra cost — contact us.
Field Specification
Mfr No TRV-0031
Accession Number NM_022153
Product Type
  • Lentiviral Vector
  • Immunotherapy Reporter Lentivirus
Reporter GFP, GFP-P2A-GLuc, GLuc, GLuc-P2A-GFP, GLuc-P2A-RFP, RFP, RFP-P2A-GLuc
Selection Marker Blasticidin, GFP (constitutively expressed), Hygromycin, Puromycin, RFP (constitutively expressed), Zeocin
Shipping Ships on dry ice; store at -80°C
Species Human

Background

VISTA (V-domain Ig suppressor of T cell activation) is an immune checkpoint receptor and ligand of the immunoglobulin superfamily, expressed predominantly on myeloid cells and, to a lesser extent, on T cells. VISTA delivers inhibitory signals that suppress T cell activation and proliferation and help maintain peripheral tolerance and a suppressive myeloid compartment. In tumors, VISTA contributes to an immunosuppressive microenvironment and immune evasion, making it an attractive checkpoint target. Because VISTA-mediated inhibition dampens NFAT-dependent transcription downstream of the T cell receptor, NFAT-driven reporters provide a quantitative readout of VISTA checkpoint signaling for immuno-oncology research.

Product Description & Applications

The VISTA/NFAT Reporter Lentivirus is an immunotherapy reporter system for studying VISTA checkpoint signaling. A receptor lentivirus constitutively expresses human VISTA with antibiotic selection, while a reporter lentivirus carries tandem NFAT response elements driving a dual reporter, secreted Gaussia luciferase and a fluorescent protein. Sequential transduction and selection generates a dual-stable cell line whose NFAT-driven reporter output reflects VISTA-modulated signaling.

Secreted Gaussia luciferase accumulates in conditioned media, enabling kinetic sampling without cell lysis, while fluorescence supports microscopy and flow cytometry. The VSV-G-pseudotyped particles are purified by PEG precipitation and sucrose gradient centrifugation and transduce difficult-to-transfect cells, including primary and thawed cultures. The system supports investigation of immune evasion, checkpoint inhibitor testing, and the role of VISTA in myeloid cell suppression.

About This Product

This 2-vial immunotherapy reporter system consists of a Vial 1 Receptor Lentivirus encoding human VISTA under a constitutive promoter with antibiotic selection, and a Vial 2 Reporter Lentivirus encoding tandem NFAT (or NF-κB) response elements driving a dual reporter (GFP, GFP-P2A-GLuc, GLuc, GLuc-P2A-GFP, GLuc-P2A-RFP, RFP, RFP-P2A-GLuc). Sequential transduction and selection generates a dual-stable effector cell line that responds quantitatively to receptor stimulation with a ratiometric fluorescent + bioluminescent readout.

Secreted Gaussia luciferase (where included) accumulates in conditioned media, enabling kinetic sampling without cell lysis. The combined fluorescent and luminescent outputs allow parallel microscopy-based visualization and plate-reader luminometry from the same cell population — providing assay redundancy and flexibility for potency testing formats compliant with regulatory expectations for cell-based functional assays.

How does this reporter lentivirus work?
What reporter and selection marker options are available?
How do I establish a stable reporter cell line?
What positive controls are recommended to validate the reporter cell line?
Can this reporter lentivirus be used in primary cells or non-adherent cells?

Can't find the lentiviral construct you need, or want to adjust key design elements? Contact us to discuss custom LV design and optional add-ons.

Common customization requests

  • Insert / payload: replace the gene/sequence, swap to a different isoform, add mutations, or optimize cloning features.
  • Expression design: change promoter (e.g., CMV/EF1α/PGK), add enhancers, or adjust regulatory elements.
  • Reporters: add/swap GFP/RFP/mCherry/luciferase (single or dual reporters where applicable).
  • Selection markers: add/swap puromycin/blasticidin/neomycin or fluorescent selection options.
  • Vector format: switch between OE, shRNA, CRISPR (sgRNA/Cas systems), or control vectors (where supported).

Add-ons you can request

  • Control viruses: empty vector, non-targeting shRNA, reporter-only controls, or matched backbone controls.
  • Packaging / format: concentration options, aliquoting, or custom fill volume for screening workflows.
  • Documentation: construct map/sequence confirmation package (as available) and batch documentation.

What to include in your request

  • Target cell type/model (cell line or primary cells) and intended readout (reporter, knockdown, OE, etc.)
  • Insert sequence (FASTA) or reference ID, plus any required tags/mutations
  • Promoter, reporter, and selection marker preferences
  • Desired scale and preferred format (aliquots / concentration requests)

Email us at support@biohippo.com or use the Talk to a Scientist request form.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today